Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$282,398
-$18,100 QoQ
Shares Held
4,193
-12.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#656
of 966 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026DoubleLine ETF Adviser LP holds $6,623,267 across 9 Medical Devices names. DXCM ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
19,764 | $1,793,385 | |
| 2 | SYK |
Stryker Corp
|
3,988 | $1,255,581 | |
| 3 | MDT |
Medtronic plc
|
14,017 | $1,096,549 | |
| 4 | BSX |
Boston Scientific Corp
|
17,556 | $749,290 | |
| 5 | EW |
Edwards Lifesciences Corp
|
6,365 | $575,777 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
6,059 | $387,836 | |
| 7 | DXCM |
Dexcom Inc
This page
|
4,193 | $282,398 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,982 | $256,720 |
All Filings in DXCM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,398 | 4,193 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $300,498 | 4,785 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||